# Assessment of Efficacy and Safety of Tegaserod Treatment and Placebo in Women With Dyspepsia

> **NCT00232089** · PHASE3 · COMPLETED · sponsor: **Novartis** · enrollment: 1296 (—)

## Conditions studied

- Dyspepsia

## Interventions

- **DRUG:** Tegaserod

## Key facts

- **NCT ID:** NCT00232089
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-05
- **Primary completion:** 2006-06
- **Final completion:** 2006-06
- **Target enrollment:** 1296 (—)
- **Last updated:** 2016-11-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00232089

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00232089, "Assessment of Efficacy and Safety of Tegaserod Treatment and Placebo in Women With Dyspepsia". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00232089. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*